Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
Files in This Item:
|Download||Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19 too many cooks.pdf||277.57 kB||Adobe PDF|
|Title:||Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?||Authors:||Geiger, Susi; McMahon, Aisling||Permanent link:||http://hdl.handle.net/10197/12764||Date:||30-Nov-2021||Online since:||2022-02-17T16:20:56Z||Abstract:||This article outlines and compares current and proposed global institutional mechanisms to increase equitable access to COVID-19 vaccines, focusing on their institutional and operational complementarities and overlaps. It specifically considers the World Health Organization's (WHO's) COVAX (COVID-19 Vaccines Global Access) model as part of the Access to COVID-19 Tools Accelerator (ACT-A) initiative, the WHO's COVID-19 Technology Access Pool (C-TAP) initiative, the proposed TRIPS (Trade-Related Aspects of Intellectual Property Agreement) intellectual property waiver and other proposed WHO and World Trade Organization technology transfer proposals. We argue that while various individual mechanisms each have their specific individual merits-and in some cases weaknesses-overall, many of these current and proposed mechanisms could be highly complementary if used together to deliver equitable global access to vaccines. Nonetheless, we also argue that there are risks posed by the proliferation of proposals in this context, including the potential to disperse stakeholder attention or to delay decisive action. Therefore, we argue that there is now a clear need for concerted global multilateral action to recognise the complementarities of specific models and to provide a pathway for collaboration in attaining global equitable access to vaccines. The institutional infrastructure or proposals to achieve this amply exist at this point in time-but much greater cooperation from industry and clear, decisive and coordinated action from states and international organisations are urgently needed.||Funding Details:||European Commission Horizon 2020
European Research Council
|Type of material:||Journal Article||Publisher:||BMJ||Journal:||Journal of Medical Ethics||Copyright (published version):||2021 the Authors||Keywords:||Ethics; Medical ethics; Social issues; Biomedical social sciences; Social sciences - other topics; Biomedical social sciences; COVID-19; Ethics - medical; Policy; Resource allocation; Coronavirus||DOI:||10.1136/medethics-2021-107684||Language:||en||Status of Item:||Peer reviewed||ISSN:||0306-6800||This item is made available under a Creative Commons License:||https://creativecommons.org/licenses/by-nc-nd/3.0/ie/|
|Appears in Collections:||Business Research Collection|
Show full item record
If you are a publisher or author and have copyright concerns for any item, please email firstname.lastname@example.org and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.